Abstract

BackgroundThe Electronic Prescription Service Release 2 (EPS2) in England has been designed to provide electronic transmission of digitally-signed prescriptions between primary care providers, with the intent on removing the large amounts of paper currently exchanged. As part of a wider evaluation of the EPS service, we wished to explore pharmacists’ experience with the new system and their perceptions of its benefits and any associated problems.MethodsWe conducted semi-structured telephone interviews with community pharmacists using EPS2. We used a purposive sampling technique to obtain views from pharmacists working in pharmacies with a range of sizes and locations and to include both independent pharmacies and multiples. Interviews were transcribed verbatim and coded using grounded theory to identify the main factors that have influenced deployment and implementation in the eyes of respondents. QSR Nvivo was used as to aid in this process.ResultsIt became apparent from the analysis that respondents perceived a wide range of advantages of EPS including improved safety, stock control, time management and improved relationships between pharmacy and General Practice staff. Respondents did not perceive a large difference in terms of work processes or development of their professional role. A large number of problems had been experienced in relation to both the technology itself and the way it was used by General Practices. It became apparent that work-around procedures had been developed for dealing with these issues but that not all these problems were perceived as having been addressed sufficiently at source. This sometimes had implications for the extent of EPS2 use and also limited some of the potential advantages of the EPS2 system, such as reduced effort in the management of prescription reimbursement. Respondents made suggestions for future improvements to EPS2. While interview data demonstrated that there were some feedback procedures in place, these were not regarded as being sufficient by the majority of respondents.ConclusionsWhilst pharmacists perceived a wide range of benefits of EPS, a large number of problems had been experienced. Despite these difficulties, no pharmacists expressed an overall negative view.

Highlights

  • The Electronic Prescription Service Release 2 (EPS2) in England has been designed to provide electronic transmission of digitally-signed prescriptions between primary care providers, with the intent on removing the large amounts of paper currently exchanged

  • The Electronic Prescription Service (EPS), NHS England’s service for the electronic transmission of prescriptions, has been designed to support a change moving from paper based transmission of prescriptions in primary care to transmission in a digital format including a digital signature

  • The role of EPS is a fundamentally simple one: it allows the transmission of prescription messages and digitallysigned prescriptions via a central network and server infrastructure, the Spine, from where they can be downloaded by dispensing contractors including community pharmacists, dispensing appliance contractors and dispensing doctors

Read more

Summary

Introduction

The Electronic Prescription Service Release 2 (EPS2) in England has been designed to provide electronic transmission of digitally-signed prescriptions between primary care providers, with the intent on removing the large amounts of paper currently exchanged. EPS1, in use since 2005, prints a barcode on the prescription form. This can be scanned by the pharmacy to initiate a download of data, the paper prescription still remains the legal entity for dispensing and reimbursement. In EPS2 a digital prescription is sent to the Spine, which a pharmacy can download and dispense. Completion of dispensing by the community pharmacy initiates a claim message to be sent to NHS Prescription Services, the body responsible for calculating reimbursements and remunerations, obviating the need for them to receive paper prescriptions

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call